AAAAAA

   
Results: 1-25 | 26-42
Results: 1-25/42

Authors: Mohr, M Dalmis, F Hilgenfeld, E Oelmann, E Zuhlsdorf, M Kratz-Albers, K Nolte, A Schmitmann, C Onaldi-Mohr, D Cassens, U Serve, H Sibrowski, W Kienast, J Berdel, WE
Citation: M. Mohr et al., Simultaneous immunomagnetic CD34+cell selection and B-cell depletion in peripheral blood progenitor cell samples of patients suffering from B-cell non-Hodgkin's lymphoma, CLIN CANC R, 7(1), 2001, pp. 51-57

Authors: Lerchenmuller, C Goner, M Buchner, T Berdel, WE
Citation: C. Lerchenmuller et al., Rhinocerebral zygomycosis in a patient with acute lymphoblastic leukemia, ANN ONCOL, 12(3), 2001, pp. 415-419

Authors: Koch, P del Valle, F Berdel, WE Willich, NA Reers, B Hiddemann, W Grothaus-Pinke, B Reinartz, G Brockmann, J Temmesfeld, A Schmitz, R Rube, C Probst, A Jaenke, G Bodenstein, H Junker, A Pott, C Schultze, J Heinecke, A Parwaresch, R Tiemann, M
Citation: P. Koch et al., Primary gastrointestinal non-Hodgkin's lymphoma: I. Anatomic and histologic distribution, clinical features, and survival data of 371 patients registered in the German Multicenter Study GIT NHL 01/92, J CL ONCOL, 19(18), 2001, pp. 3861-3873

Authors: Koch, P del Valle, F Berdel, WE Willich, NA Reers, B Hiddemann, W Grothaus-Pinke, B Reinartz, G Brockmann, J Temmesfeld, A Schmitz, R Rube, C Probst, A Jaenke, G Bodenstein, H Junker, A Pott, C Schultze, J Heinecke, A Parwaresch, R Tiemann, M
Citation: P. Koch et al., Primary gastrointestinal non-Hodgkin's lymphoma: II. Combined surgical andconservative or conservative management only in localized gastric lymphoma- Results of the Prospective German Multicenter Study GIT NHL 01/92, J CL ONCOL, 19(18), 2001, pp. 3874-3883

Authors: Rick, O Bokemeyer, C Beyer, J Hartmann, JT Schwella, N Kingreen, D Neureither, S Metzner, B Casper, J Wandt, H Hartmann, F Schmoll, HJ Derigs, G Gerl, A Berdel, WE Kanz, L Siegert, W
Citation: O. Rick et al., Salvage treatment with paclitaxel, ifosfamide, and cisplatin plus high-dose carboplatin, etoposide, and thiotepa followed by autologous stem-cell rescue in patients with relapsed or refractory germ cell cancer, J CL ONCOL, 19(1), 2001, pp. 81-88

Authors: Mesters, RM Padro, T Steins, M Bieker, R Retzlaff, S Kessler, T Kienast, J Berdel, WE
Citation: Rm. Mesters et al., Angiogenesis in patients with hematologic malignancies, ONKOLOGIE, 24, 2001, pp. 75-80

Authors: Cassens, U Momkvist, PH Zuehlsdorf, M Mohr, M Kienast, J Berdel, WE Sibrowski, W
Citation: U. Cassens et al., Kinetics of standardized large volume leukapheresis (LVL) in patients do not show a recruitment phenomenon of peripheral blood progenitor cells (PBPC), BONE MAR TR, 28(1), 2001, pp. 13-20

Authors: Thomas, M Broermann, P Droege, C Lerchenmuller, C Berdel, WE
Citation: M. Thomas et al., Development of treatment strategies in locally advanced non-small cell lung cancer (take home messages), LUNG CANC, 33, 2001, pp. S91-S97

Authors: Muller-Tidow, C Bornemann, C Diederichs, S Westermann, A Klumpen, S Zuo, PJ Wang, WB Berdel, WE Serve, H
Citation: C. Muller-tidow et al., Analyses of the genomic methylation status of the human cyclin A1 promoterby a novel real-time PCR-based methodology, FEBS LETTER, 490(1-2), 2001, pp. 75-78

Authors: Muller-Tidow, C Metzger, R Kugler, K Diederichs, S Idos, G Thomas, M Dockhorn-Dworniczak, B Schneider, PM Koeffler, HP Berdel, WE Serve, H
Citation: C. Muller-tidow et al., Cyclin E is the only cyclin-dependent kinase 2-associated cyclin that predicts metastasis and survival in early stage non-small cell lung cancer, CANCER RES, 61(2), 2001, pp. 647-653

Authors: Hilgenfeld, E Padilla-Nash, H McNeil, N Knutsen, T Montagna, C Tchinda, J Horst, J Ludwig, WD Serve, H Buchner, T Berdel, WE Schrock, E Ried, T
Citation: E. Hilgenfeld et al., Spectral karyotyping and fluorescence in situ hybridization detect novel chromosomal aberrations, a recurring involvement of chromosome 21 and amplification of the MYC oncogene in acute myeloid leukaemia M2, BR J HAEM, 113(2), 2001, pp. 305-317

Authors: Muller-Tidow, C Kugler, K Diederichs, S Klumpen, S Moller, M Vogt, U Metzger, R Schneider, PM Berdel, WE Serve, H
Citation: C. Muller-tidow et al., Loss of expression of HDAC-recruiting methyl-CpG-binding domain proteins in human cancer, BR J CANC, 85(8), 2001, pp. 1168-1174

Authors: Renz, A Berdel, WE Kreuter, M Belka, C Schulze-Osthoff, K Los, M
Citation: A. Renz et al., Rapid extracellular release of cytochrome c is specific for apoptosis and marks cell death in vivo, BLOOD, 98(5), 2001, pp. 1542-1548

Authors: Mesters, RM Padro, T Bieker, R Steins, M Kreuter, M Goner, M Kelsey, S Scigalla, P Fiedler, W Buchner, T Berdel, WE
Citation: Rm. Mesters et al., Stable remission after administration of the receptor tyrosine kinase inhibitor SU5416 in a patient with refractory acute myeloid leukemia, BLOOD, 98(1), 2001, pp. 241-243

Authors: Muller-Tidow, C Wang, WB Idos, GE Diederichs, S Yang, R Readhead, C Berdel, WE Serve, H Saville, M Watson, R Koeffler, HP
Citation: C. Muller-tidow et al., Cyclin A1 directly interacts with B-myb and cyclin A1/cdk2 phosphorylate B-myb at functionally important serine and threonine residues: tissue-specific regulation of B-myb function, BLOOD, 97(7), 2001, pp. 2091-2097

Authors: Mizuki, M Gruning, W Schmidt, R Serve, S Fenski, R Kratz-Albers, K Buchner, T Kienast, J Berdel, WE Serve, H
Citation: M. Mizuki et al., Transforming activity of Flt3 in 32D cells, HEMAT BLOOD, 40, 2001, pp. 146-151

Authors: Padro, T Ruiz, S Burger, RH Steins, M Bieker, R Kienast, J Buchner, T Bocker, W Berdel, WE Mesters, RM
Citation: T. Padro et al., Evidence of angiogenesis in acute myeloid leukemia, HEMAT BLOOD, 40, 2001, pp. 152-159

Authors: Lerchenmuller, C Berdel, WE Buchner, T
Citation: C. Lerchenmuller et al., Phase I study of liposomal daunorubicin (DaunoXome) in relapsed and refractory acute myeloid leukemia, HEMAT BLOOD, 40, 2001, pp. 191-195

Authors: Schumacher, A Wewers, D Buchner, T Berdel, WE
Citation: A. Schumacher et al., Including quality of life as an important end point in evaluating intensive and prolonged treatment for acute myeloid leukemia (AML), HEMAT BLOOD, 40, 2001, pp. 482-487

Authors: Scheulen, ME Hilger, RA Oberhoff, C Casper, J F'reund, M Josten, KM Bornhauser, M Ehninger, G Berdel, WE Baumgart, J Harstrick, A Bojko, P Wolf, HH Schindler, AE Seeber, S
Citation: Me. Scheulen et al., Clinical phase I dose escalation and pharmacokinetic study of high-dose chemotherapy with treosulfan and autologous peripheral blood stem cell transplantation in patients with advanced malignancies, CLIN CANC R, 6(11), 2000, pp. 4209-4216

Authors: Matzkies, FK Tombach, B Dietrich, M Kisters, K Barenbrock, M Schaefer, RM Berdel, WE Rahn, KH
Citation: Fk. Matzkies et al., MVAC-therapy for advanced urothelial carcinoma in an anuric renal transplant recipient, NEPH DIAL T, 15(1), 2000, pp. 110-112

Authors: Koch, P Berdel, WE Willich, N Tieman, M Parwaresch, R
Citation: P. Koch et al., Grading in marginal-zone lymphomas, J CL ONCOL, 18(14), 2000, pp. 2788-2788

Authors: Mross, K Robben-Bathe, P Edler, L Baumgart, J Berdel, WE Fiebig, H Unger, C
Citation: K. Mross et al., Phase I clinical trial of a day-1,-3,-5 every 3 weeks schedule with titanocene dichloride (MKT 5) in patients with advanced cancer - A study of the phase I study group of the Association for Medical Oncology (AIO) of the German Cancer Society, ONKOLOGIE, 23(6), 2000, pp. 576-579

Authors: Muller, C Readhead, C Diederichs, S Idos, G Yang, R Tidow, N Serve, H Berdel, WE Koeffler, HP
Citation: C. Muller et al., Methylation of the cyclin A1 promoter correlates with gene silencing in somatic cell lines, while tissue-specific expression of cyclin A1 is methylation independent, MOL CELL B, 20(9), 2000, pp. 3316-3329

Authors: Szelenyi, H Hohenberger, P Lochs, H Haboubi, N Berdel, WE Thiel, E Kreuser, ED
Citation: H. Szelenyi et al., Sequential trimetrexate, 5-fluorouracil and folinic acid are effective andwell tolerated in metastatic colorectal carcinoma, ONCOL-BASEL, 58(4), 2000, pp. 273-279
Risultati: 1-25 | 26-42